Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

6.3%

1 terminated/withdrawn out of 16 trials

Success Rate

92.3%

+5.8% vs industry average

Late-Stage Pipeline

13%

2 trials in Phase 3/4

Results Transparency

0 of 12 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

8(50.0%)

Phase 1

3(18.8%)

Phase 3

2(12.5%)

Phase 2

2(12.5%)

Early Phase 1

1(6.3%)

16Total

N/A(8)

Phase 1(3)

Phase 3(2)

Phase 2(2)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (16)

Showing 16 of 16 trials

NCT04427930Phase 3Active Not Recruiting

Follow-up Study for Participants of Jointstem Phase 3 Clinical Trial

Role: lead

NCT03990805Phase 3Completed

A Phase 3 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis

Role: lead

NCT03509025Phase 2Completed

Follow-up Study for Participants Jointstem Clinical Trial

Role: lead

NCT04825730Not ApplicableNot Yet Recruiting

Follow-up Study for Participants of Jointstem Investigator Initiated Trial by Arthroscopy

Role: lead

NCT04821102Not ApplicableUnknown

Investigator Initiated Trial to Evaluate Cartilage Regeneration by Arthroscopy After JOINTSTEM Administration

Role: lead

NCT03000712Not ApplicableCompleted

Investigator Initiated Trial to Evaluate the Efficacy and Safety of Intra-articular Injection of ADMSC Comared to Negative Control After High Tibial Osteotomy in the Osteoarthritis Patients.

Role: lead

NCT03979898Early Phase 1Completed

Safety and Effectiveness of Autologous Adipose Tissue Derived Mesenchymal Stem Cell Implantation in Patients With CP

Role: lead

NCT01643681Not ApplicableWithdrawn

Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Lumbar Intervertebral Disc Degeneration

Role: lead

NCT02658344Phase 2Completed

Clinical Trial to Evaluate Efficacy and Safety of JOINTSTEM in Patients With Degenerative Arthritis

Role: lead

NCT01309061Not ApplicableCompleted

The Effect of Human Adipose Tissue-derived MSCs in Romberg's Disease

Role: lead

NCT01663376Not ApplicableCompleted

Safety and Effect of Adipose Tissue Derived Mesenchymal Stem Cells Implantation in Patients With Critical Limb Ischemia

Role: lead

NCT01300598Phase 1Completed

Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Degenerative Arthritis

Role: lead

NCT01302015Not ApplicableCompleted

Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Buerger's Disease

Role: lead

NCT01643655Not ApplicableCompleted

Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Avascular Necrosis of the Femoral Head

Role: lead

NCT01769872Phase 1Completed

Safety and Effect of Adipose Tissue Derived Mesenchymal Stem Cell Implantation in Patients With Spinal Cord Injury

Role: lead

NCT01274975Phase 1Completed

Autologous Adipose Derived MSCs Transplantation in Patient With Spinal Cord Injury.

Role: lead

All 16 trials loaded